Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Slutsky covers the Healthcare sector, focusing on stocks such as Spyre Therapeutics, Palvella Therapeutics, and Enliven Therapeutics. According to TipRanks, Slutsky has an average return of 44.6% and a 52.24% success rate on recommended stocks.
In a report released on May 14, Bank of America Securities also maintained a Buy rating on the stock with a $83.00 price target.
Based on CG Oncology, Inc.’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $1.08 million and a GAAP net loss of $60.2 million. In comparison, last year the company earned a revenue of $52 thousand and had a GAAP net loss of $34.45 million
